Announcements Trials
Browse Landscape

Phase

Phase 2 23Phase 1 10Phase 1/2 5Phase 3 4Phase NA 3Phase EARLY_PHASE1 2Phase 4 1Phase 2/3 1

Status

Completed 16Recruiting 12Active not recruiting 8Terminated 4Unknown 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Gastrointestinal 147Thoracic 125Genitourinary 96Breast 95Lymphoid 83Other hematologic neoplasm 76Gynecologic 51Head & Neck 41Dermatologic 33Myeloid 27Plasma cell 26CNS 25Sarcoma 23Classical hematology 23Other 13Endocrine 11Tumor-Agnostic 6NET 4Other solid neoplasm 3Other neoplasm 3

Conditions

Neuroendocrine Tumors 2Neuroendocrine Tumors in Lung 1Digestive Neuroendocrine Tumors 1Carcinoid Tumor 1

Interventions

lanreotide 1Somatostatin 1Serotonin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 3 × Terminated × NET × Clear all
NCT02683941 2022-07-06

SPINET

Ipsen

Phase 3 Terminated
77 enrolled 20 charts
EndocrineNET

Neuroendocrine Tumors in Lung

NCT02465112 2019-02-28

TERAVECT

GERCOR - Multidisciplinary Oncology Cooperative Group

Phase 3 Terminated
4 enrolled
EndocrineNET

Digestive Neuroendocrine Tumors

NCT00227136 2018-04-13

Effect of Oral 5-HTP Intake on Urinary 5-HIAA Excretion

Western University, Canada

Phase 3 Terminated
8 enrolled
EndocrineNET

Carcinoid Tumor, Neuroendocrine Tumors

NCT01755182 2016-05-06

LOTUS

National Cancer Institute, Naples

Phase 3 Terminated
1 enrolled
EndocrineNET

Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡